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Abstract
Dental caries remains one of the most common chronic diseases worldwide. Salivary proteins
such as histatins have demonstrated biological functions directly related to tooth homeostasis
and prevention of dental caries. However, histatins are susceptible to the high proteolytic
activities in the oral environment. Therefore, pH-sensitive chitosan nanoparticles (CNs) have
been proposed as potential carriers to target major oral diseases that occur under acidic
conditions (e.g. dental caries and dental erosion). Four different types of chitosan polymers
were investigated and the optimized CNs successfully loaded histatin 3 and released it
selectively under acidic conditions. Through loading the survival time of histatin 3 was
increased by two-fold in diluted whole saliva. Results from biofilm experiment have
demonstrated both blank and histatin 3-loaded CNs were able to reduce biofilm growth of
Streptococcus mutans. The results of this study have demonstrated the potential of using blank
CNs alone as antibacterial agent for oral applications in addition to the potential of CNs as
protein carriers, especially for diseases occurring at acidic conditions.
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Chapter 1
1.

Introduction

1.1 Dental Caries and Their Prevalence
Dental caries, also known as tooth decay, remains one of the most common chronic
diseases worldwide (Kassebaum et al. 2015; Frencken et al. 2017). Globally,
approximately 2.4 billion people (32% of the world population) have experienced dental
caries in their permanent teeth (James et al. 2018). The severity of dental caries is
dependent on many factors including susceptibility of the tooth surface, the frequency of
sugar intake, oral hygiene behavior, and the presence of cariogenic bacteria (Garcia et al.
2017). Untreated dental caries has often been associated with a negative impact on quality
of life, such as discomfort caused by toothache, pain-induced lack of appetite, foul breath,
prolonged exposure to oral inflammation, and other symptoms.

Figure 1.1 Major components of the tooth are displayed. Enamel is the surface layer
covering the dentin. Dentin in turn covers the pulp. Extending down to the root,
dentin is covered by the cementum. (K.D. Schroeder, human tooth diagram-en.svg
from Wikimedia Commons. Licensed under CC BY-SA 4.0.)
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The structure of the tooth is presented in Figure 1.1. Enamel is the outermost layer
covering the dentin, which covers the pulp. Moving down to the root, the dentin is now
covered by the cementum. A caries lesion has penetrated into the dentin from the enamel
layer, as labelled on Figure 1.1. There are many stages of dental caries. The carious
dissolution of dental hard tissue always starts with the tooth surface. The surface is not
limited to enamel surface. Root cementum and exposed dentin are also possible surfaces
for caries to develop. However, in most cases, caries usually affects the enamel layer first.
At this stage, the damage is still reversible. When the caries reaches into dentin, current
treatment requires a filling procedure to be performed. If the caries penetrates deeper into
the root of the teeth, this could lead to possible damage of the tooth nerve, which may result
in tooth loss and infection (Cochrane et al. 2010; Wong et al. 2017).
Dental caries is a complex multifactorial disease that results in mineral dissolution
of the dental hard tissues (enamel, dentin and cementum) by acidic by-products of bacteria
through fermentation of dietary carbohydrates. Caries is a dynamic process between
pathological and protective factors, as presented in Figure 1.2. Pathological factors include
acidogenic bacteria that ferment dietary carbohydrates into different types of acids. These
acids then diffuse into the enamel, dentin, or cementum, leading to partial mineral
dissolution. Dissolved mineral content (calcium and phosphate) diffuses out of the tooth
and the resulting loss in mineral content is known as demineralization (Marsh 2009). This
eventually leads to cavitation if the process progresses. Other factors include reduced
salivary functions such as reduced saliva flow and imbalanced salivary composition.
Increased frequency of carbohydrate intake also increases the risk of caries development.
Demineralization can be reversed by the diffusion of minerals like calcium, phosphate, and
fluoride. They can be deposited back onto the remaining mineral remnants caused by
demineralization (Featherstone 2004). The process of mineral gains is referred to as
remineralization (Tung and Eichmiller 2004) and it is promoted by protective factors such
as saliva, proteins and fluoride.
The acidic by-products can be neutralized by saliva due to its bicarbonate/carbonate
buffering capacity. Fluoride solution or fluoride containing oral products may also promote
remineralization (Kanduti et al. 2016).

The dynamic process of demineralization and

3

remineralization happens many times a day, usually after carbohydrate intake from food or
drinks. Dental caries occurs when the demineralization process initiated by the pathological
factors dominates, and as a result there is a net loss of mineral content. If the balance is
shifted towards the remineralization process promoted by protective factors, development
of caries stops or reverses.

Figure 1.2 Schematic representation of the balance between protective factors and
pathological factors and how they affect the development of caries. Reprinted with
permission from Featherstone 2004. Copyright 2004 SAGE Publications.
For demineralization to occur, the salivary pH needs to drop below a certain level.
The Stephan curve – first described by Stephan and Miller in the 1940s – depicts salivary
pH changes in the mouth after rinsing with glucose, corresponding to the pH changes
observed in saliva following sugar intake (Bowen 2013). As presented in Figure 1.3, the
resting salivary pH without exposure to sugar usually has a pH value between 6 and 7. This
varies for each individual, but remains stable until carbohydrate intake (Sissons et al.
1998). The salivary pH was observed to drop rapidly following carbohydrate consumption.
The critical level was defined at pH 5.5 where demineralization of the enamel will begin

4

to occur. The pH level may remain below this critical level for approximately 20 minutes,
and recovery to resting pH may take about 30 to 60 mins.

Figure 1.3 Stephan curve illustrating the change in pH following carbohydrate
ingestion. The critical level is defined at pH 5.5 and is represented by the pink line.
At/below the critical level, demineralization will occur, consequently increasing caries
risk.
The most common preventive approach is good oral hygiene practices, including
brushing twice a day and the use of dental floss. Regular visits to the dentist for mechanical
removal of dental plaque is another effective way to reduce caries risk (Finkelstein et al.
1990). Fluoride treatment is often provided in conjunction with mechanical cleaning, which
reduces the demineralization process and promotes remineralization of enamel by
absorbing onto the enamel to form fluorohydroxyapatite. The resulting enamel is
strengthened and becomes more resistant to demineralization (Buzalaf et al. 2011).
Fluoride containing toothpaste is already common in North America and Europe, but it is
only effective at concentrations higher than 1,000 ppm. However, the new challenge that
arises is the increased frequency of daily sugar consumption. As illustrated in Figure 1.4,
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frequent snack/coffee breaks between meals result in increased exposure to cariogenic
(acidic) environments. The extended duration of exposure to pH under the critical level
(pH 5.5) can promote demineralization, which increases the risk of caries development. A
potential effective preventive approach would be to inhibit bacterial activity to prevent or
shorten the demineralization process.

Figure 1.4 Frequent sugar intake increases exposure to acidic conditions, which can
increase caries risk.

1.2 AEP and its Role in Regulating Biofilm Formation
Saliva is another protective factor that was mentioned in the previous section. It is
a complex fluid composed of proteins, enzymes, and a variety of electrolytes. Many
physiological functions are regulated by saliva, such as chewing, initial digestion of food,
wetting, and lubrication (Humphrey and Williamson 2001; Siqueira and Dawes 2011).
Saliva also plays an active role in the maintenance of oral health, including partial
protection against microbial activities, the maintenance of both salivary pH and tooth
integrity (Mandel 1987). The inorganic ions present in saliva are mainly calcium and
phosphate. They remain at a supersaturation state with respect to hydroxyapatite (HA)
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crystal, the major component of tooth enamel. This supersaturation of calcium and
phosphate ions promotes remineralization of the tooth enamel by allowing the diffusion of
these ions into the HA. However, the remineralization process is mainly regulated by
salivary proteins which constitute the acquired enamel pellicle (AEP) (Valente et al. 2018).
AEP is a thin proteinaceous film formed on the tooth surface by selective adsorption
of salivary proteins and other molecules present in the oral fluids. Its formation is initiated
within seconds of exposure to whole saliva after oral cleaning (Siqueira et al. 2012). AEP
serves as a platform which allows bacterial adhesion for the development of biofilm. The
oral cavity harbors many different types of microorganisms. Some of the primary
colonizers which attach themselves to the AEP are the Streptococcus species, Actinomyces
species and Haemophilus species (Dige et al. 2009; Huang et al. 2011; Dorkhan et al.
2013). Secondary colonizers such as Fusobacterium nucleatum, Treponema species, and
Tannerella forsythensis, bind onto already attached primary bacteria by co-adhesion or coaggregation (Kolenbrander et al. 2002; Foster and Kolenbrander 2004). The composition
of the biofilm becomes more diversified. The mature biofilm is commonly known as a
dental plaque. The dental plaque remains relatively stable over time under microbial
homeostasis. However, when the microbial composition favors acidogenic species such as
Streptococcus mutans (S. mutans) (Marsh 2006), the extended exposure to acidic
conditions initiates demineralization and paves the way for the development of caries.
AEP serves multiple functions due to its physical structure and salivary proteins.
The physical structure prevents direct contact between acids produced by acidogenic
bacteria and the tooth surface. This intervention reduces mineral dissolution of the tooth
(Moreno and Zahradnik 1979; Hannig et al. 2004; Hara et al. 2006). The physical structure
also plays a crucial role in regulating the attachment of early microbial colonizers.
Therefore, it is reasonable to propose that modulation of the composition or structure of
the AEP is a potential preventive approach for dental caries. In previous research, salivary
proteins identified from the AEP such as histatin (HTN) and statherin have demonstrated
strong affinity for HA. The ability of the proteins to prevent the precipitation of calcium
and phosphate on tooth enamel (Valente et al. 2018) in addition to modulation of the AEP
structure could also potentially affect attachment of cariogenic bacteria.
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1.3 Discovery of Salivary Proteins and Their Functions
Salivary proteins play a crucial role in regulating oral homeostasis, either by
directly exerting antimicrobial effects or interference with microbial colonization.
Examples of these antimicrobial peptides (AMPs) include cathelicidin peptide LL-37,
alpha-defensins, beta-defensins, HTN and statherin. Other salivary proteins that are present
include major glycoproteins (mucins, proline-rich proteins and immunoglobulins) and
minor glycoproteins (agglutinin, lactoferrin, cystatins and lysozyme) (Hemadi et al. 2017).
In particular, AMPs have received attention due to their innate immunity. They are
often thought of as the first line of defense against oral infection (Brogden 2005). The HTN
family is of great interest because these proteins are multifunctional. They have
demonstrated biological functions including the inhibition of calcium and phosphate
precipitation on enamel, and antimicrobial activities which are directly related to the
regulation of oral homeostasis (Oppenheim et al. 2007; Siqueira et al. 2010; Walter L.
Siqueira et al. 2012). HTN family proteins are characterized by histidine-rich structures
ranging from 7 to 38 amino acids (Johnson et al. 2000). The most commonly expressed
forms are HTN1, HTN3, and HTN5, which have molecular weights of 4929, 4063, and
3037 Daltons respectively. Each form comprises about 20-30% of the total HTN pool
(Gusman et al. 2004). HTN1 is postulated to play a role in reducing bacterial binding
because it is one of the salivary proteins that constitutes the AEP. Previous studies have
demonstrated its potential in reducing S. mutans adhesion onto HA discs by inhibiting the
adsorption of S. mutans-binding salivary glycoproteins (Shimotoyodome et al. 2006;
Vitorino et al. 2008). HTN5 has the most potent antifungal activity against Candida
albicans, which is a pathogenic yeast (Puri and Edgerton 2014) that can survive under
highly acidic environments and has a high affinity for HA substrates. It also can promote
demineralization by dissolving HA through loss of calcium ions (Klinke et al. 2009). HTN3
was demonstrated to be the most effective in killing S. mutans (Basiri et al. 2017), which
is the most common cariogenic bacterial species present in dental plaque. Through
metabolization of dietary sucrose S. mutans can produce sticky polysaccharides which
function as platforms for further bacterial attachment on the tooth surface. Other simple
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sugars can also be digested to produce acidic products. The acidic environment causes the
mineral-rich tooth enamel to become susceptible to mineral dissolution. HTN3 has the
potential to inhibit bacterial activities, possibly preventing or shortening the
demineralization process, and therefore decreasing caries risk.
Statherin is another salivary protein derived from the AEP, and has been observed
to have a strong binding affinity and fast adsorption to HA (Zimmerman et al. 2013).
Previous studies have demonstrated its ability to regulate calcium phosphate homeostasis.
The presence of a covalently linked phosphate group at residues 2 and 3 in statherin
peptides can modulate the effect of crystal growth inhibition on HA. This ability makes it
a significant contributor to the maintenance of the supersaturation states of calcium and
phosphate in saliva (Xiao et al. 2015). Supersaturation of calcium and phosphate is
important because it allows enamel to remineralize after transient mineral loss, and inhibits
the formation of dental calculus (Hay et al. 1984). Notably, due to proteolytic degradation,
statherin levels are substantially lower in whole saliva than in salivary gland secretion
(Oppenheim et al. 2007). Therefore, this prevents statherin from being used directly for
protein-mediated homeostasis therapeutic.

1.4 Polymer-based Delivery Systems
Despite the multifunctionality of salivary proteins, they are often present in low
concentrations (Fábián et al. 2012) due to their susceptibility to the high proteolytic activity
in the oral environment (Helmerhorst et al. 2006). Therefore, to use these proteins as
potential therapeutics, a delivery system is needed to encapsulate them thereby affording
protection against enzymatic degradation.
The utilization of stimulus-responsive polymeric nanoparticles to deliver
therapeutics has gained substantial attention in the past decade. Smart delivery systems
offer many advantages over conventional dosage forms. Polymeric delivery systems have
the potential to improve overall stability, prolong circulation time, and modulate
pharmacokinetics, often with reduced toxicity and enhanced efficacy (Mihu et al. 2010;
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Yang et al. 2010; Shen et al. 2012; Xiong et al. 2012). Ideally, therapeutics of interest
would remain stable inside the delivery system in the absence of a stimulus. Upon stimulus
exposure, the delivery system will trigger the release of encapsulated therapeutics. As
illustrated in Figure 1.5, stimuli are often categorized based on their properties. Biological
cues include enzymes and receptors. Chemical stimuli consist of pH, ionic strength, and
electrochemical signals. Lastly, physical stimuli include light, temperature, magnetic field,
and ultrasound. Different stimuli-responsive systems can be designed to selectively
respond to transient environmental changes that reflect the pathogenic state (Lee et al.
2003; Basel et al. 2011; Chen et al. 2014).

Figure 1.5 Stimuli utilized in drug delivery applications are categorized based on their
properties. For example, physical stimuli include temperature, light and ultrasound.
Reprinted with permission from Delcea et al. 2011. Copyright 2011 Elsevier.
Many polymeric materials have been explored to prepare a nanoparticle-based
delivery system. Two main categories are natural and synthetic polymers (Blasi et al. 2007;
Kumari et al. 2010). In particular, naturally occurring polymers are of great interest because
of their unique physical and biological properties. This category includes polysaccharides,
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proteins, and polyisoprenes (Ravve 2000). Polysaccharides are polymers of
monosaccharides that are abundant in nature. They have a variety of functional groups,
which contribute to their diversified structures and properties. In recent years, research has
demonstrated the suitability of polysaccharides, including alginate, chitosan and starch as
potential candidates for applications in a nanoparticle-based drug delivery system
(Anirudhan et al. 2017; Choudhary et al. 2019; Zheng et al. 2019).
As the only naturally occurring polycationic polysaccharide discovered so far and
with its ability to interact with anionic molecules, chitosan and its derivatives have been
studied extensively for applications in the agricultural, medicinal and pharmaceutical
industries (Souza et al. 2014; Bugnicourt and Ladavière 2016; Olivera et al. 2016).
Chitosan is a copolymer composed of N-acetyl-D-glucosamine and β (1-4) linked Dglucosamine. It is prepared by treating natural polymer chitin with alkaline chemicals,
through a process called deacetylation. Chitin is a primary structural component found in
the cell walls of fungi, exoskeletons of crustaceans, and is one of the most abundant
polysaccharides existing in nature (Ravi Kumar 2000). Chitosan also offers other
advantages including biodegradability (Kean and Thanou 2010), biocompatibility
(Thandapani et al. 2017), and pH-dependent solubility (Cha et al. 2006). As demonstrated
in Figure 1.6, under high pH conditions, the amino group becomes deprotonated, resulting
in a low solubility in water. Consequently, the polymer chains will cluster together to form
a more compact structure. When the amino group is protonated under low pH conditions,
the increased solubility in water allows the polymer chain to exhibit a more extended
structure.
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Figure 1.6 Structural changes of chitosan affect its solubility. When the amino group
is protonated under low pH conditions, it becomes more soluble. Solubility is low
when the amino group becomes deprotonated under high pH conditions. Reprinted
with permission from Ali and Ahmed 2018. Copyright 2018 Elsevier.
Chitosan-based delivery systems have been explored due to their aforementioned
advantageous properties. Chitosan has been formulated into different carriers such as
microspheres (Zhang et al. 2013), hydrogels (Sadat Ebrahimi and Schönherr 2014), beads
(Chandy and Sharma 1992) and nanoparticles (Sarmento et al. 2007). For the delivery of
small proteins/peptides, nanoparticles are more advantageous because of their high surface
area to volume ratios. There are many different methods to synthesize chitosan
nanoparticles (CNs). Some common approaches are ionic gelation, covalent cross-linking,
emulsification solvent diffusion and self-assembly.
Ionic gelation occurs through electrostatic interactions between chitosan or its
derivatives with an ionic cross-linking agent of opposite charge. Among polyanionic crosslinking agents, the most commonly used is sodium tripolyphosphate (TPP), which is nontoxic and widely used as a preservative in the food industry (Kawashima et al. 1985). In
this method, chitosan polymer is dissolved in acetic acid, while TPP is dissolved in
Millipore water. The TPP solution is then added into the chitosan solution in a drop-wise
manner under constant mechanical stirring. Positively charged chitosan polymer chains
interact electrostatically with the negatively charged TPP under mechanical stirring, as
illustrated in Figure 1.7. The advantages of this method include its simplicity to perform
and scale up, as it can be performed at room temperature without the use of any organic
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solvent. Previous studies have investigated the ability of CNs prepared via ionic gelation
to encapsulate peptides/proteins, oligonucleotides, and drugs for potential pharmaceutical
applications (Sezer and Akbuǧa 1995; Aydin and Akbuǧa 1996; Shu and Zhu 2000).

Figure 1.7 CNs prepared by ionic gelation with TPP, TPP solution was added to
chitosan solution in a drop-wise manner under constant mechanical stirring, CNs will
form based on the electrostatic interactions between the two oppositely charge
species. Reprinted from Wang et al. 2016. Licensed under CC BY 4.0.
Another technique for preparing CNs is through covalent cross-linking (Prabaharan
and Mano 2005). This involves the formation of a covalent bond between the chitosan
polymer chain with a cross-linking agent. Some functional groups that could be covalently
attached to the amino groups on the chitosan chain include polyethylene glycol,
dicarboxylic acid, and glutaraldehyde (Bodnar et al. 2005; Goldberg et al. 2007). This
method was first used to prepare chitosan nanoparticles by cross-linking with
glutaraldehyde to encapsulate 5-fluorouracil (Ohya et al. 1993).
CNs can also be prepared by emulsification solvent diffusion method. An emulsion
is prepared by injecting an organic solvent into chitosan solution under high-pressure
homogenization. Subsequently, a large amount of water is added to the emulsion. Polymer
precipitation occurs following the diffusion of organic solvent into water, consequently
leading to the formation of CNs (El-Shabouri 2002). This method is desirable to

13

encapsulate hydrophobic drugs with a high encapsulation efficiency. However, the major
disadvantages are the use of organic solvent and high shear forces (Wang et al. 2016).
Self-assembly of nanoparticles refers to the process of spontaneous formation of
nanoparticles when amphiphilic compounds are dispersed in water. A core-shell structure
will be formed with a hydrophilic moiety on the periphery and a hydrophobic moiety
clustered in the core. The main advantage of this method is that poorly water-soluble
molecules, such as anticancer drugs, can be successfully loaded into the hydrophobic core
of modified CNs. One previous study used chemically modified glycol chitosan with
hydrophobic cholinic acid and prepared nanoparticles via self-assembly after dispersion in
water solution. The hydrophobic core successfully encapsulated the poorly water-soluble
anticancer drug cisplatin with a drug loading of 80%. Through encapsulation, cisplatin was
released in a sustained manner for a week, and the toxicity profile was also improved (Kim
et al. 2008). Another study involved modified chitosan polymer with alkyl chains as the
hydrophobic moiety and glycol groups as the hydrophilic moiety. The synthesized CNs
were able to improve the solubility of the poorly water-soluble antitumor drug paclitaxel
by 500-fold, at a drug loading of 35% (Huo et al. 2010).
CNs can encapsulate a variety of cargo aside from anticancer drugs, which include
gene therapeutics, protein drugs, and more (Sarmento et al. 2007; Han et al. 2010). CNs
can be administered orally, nasally, and intravenously. Most cargo cannot survive for very
long when administered on their own. For example, gene silencing mediated by siRNA has
demonstrated potential for treating diseases caused by genetic defects. However, when
delivered alone, it faces challenges including rapid degradation and poor cellular uptake.
Through encapsulation of CNs prepared via ionic gelation between chitosan and TPP, CNs
were able to protect siRNA against degradation by nucleases. The positive charge of
siRNA CNs also improved adsorption onto the cell surface. However, gene transfection
efficiency was low as a result of encapsulation (Katas and Alpar 2006). This was later
addressed by optimizing the properties of chitosan, including molecular weight and degree
of deacetylation. With chemical modification of chitosan using folic acid, the optimized
folic acid modified CNs were able to demonstrate an equivalent transfection efficiency
compared against the positive control group (Lavertu et al. 2006) .
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Protein drugs are susceptible to enzymatic degradation and therefore have poor
overall stability and short survival time. In the past, insulin and a cationic β-cyclodextrin
complex has been encapsulated into alginate-CNs. The delivery system was not only able
to protect insulin against degradation from simulated gastric fluid, but it also cumulatively
released approximately 40% of the encapsulated insulin under simulated intestinal fluid
(Zhang et al. 2010).

1.5 Rationale and Focus of this Work
In the current work, HTN3 has been selected as the protein of interest due to its
antibacterial property against S. mutans. Through loading of HTN3 within CNs, the
delivery system should remain stable at physiological salivary pH to protect the loaded
HTN3 against enzymatic degradation. The pH-responsive property of CNs should allow
selective release of HTN3 under acidic conditions, as shown below in Figure 1.8.
The pH-responsive behaviour of HTN3-loaded CNs is important, because the
salivary pH drops every time after carbohydrate intake. The acidic conditions promote
major oral complications such as dental caries and dental erosion (Nikaido et al. 2004).
The drop in pH should trigger the immediate release of loaded HTN3. The released HTN3
may inhibit bacterial fermentation of ingested carbohydrate, possibly preventing or
shortening the exposure to acidic environment and reducing demineralization.
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Figure 1.8 A schematic representation of the pH-sensitive release mechanism
exhibited by CNs. HTN3 remains inside of CNs under physiological salivary pH. The
CNs will swell selectively under acidic conditions to release loaded HTN3.

1.6 Thesis Outline
The central hypothesis of this thesis is that I can develop a pH-sensitive CN delivery
system, which can be utilized to load multifunctional salivary proteins for targeting major
oral complications that occur under acidic conditions.
Chapter 2, describes the study of different types of chitosan polymers to select the
optimal CNs formulation. The optimized CNs formulation was characterized by dynamic
light scattering and visualized by transmission electron microscopy. The pH-responsive
property of the CNs was also assessed through pH-dependent swelling and pH cycling
studies. Secondly, the protein of interest, HTN3 was loaded into CNs and different protein
loading ratios were studied thoroughly. Cumulative and pH cycling release profiles under
different pH conditions were also evaluated. Additionally, a protein degradation study was
performed to evaluate the protection offered by loading against enzymatic degradation.
Lastly, the therapeutic effect of HTN3-loaded CNs against S. mutans biofilm formation on
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hydroxyapatite discs was evaluated based on biofilm weight and bacterial cell viability.
The results were compared against four other treatment groups: PBS (control), free HTN3,
unloaded CNs, and gold standard fluoride solution.
In chapter 3, a general conclusion is presented based on the collected data. The
significance, possible improvements, and future work regarding this project are also
discussed.
The ultimate goal of this project is to formulate CN-based dental hygiene products
like toothpaste and mouthwash. With the development of HTN3-loaded CNs, the results of
this work could potentially advance the delivery of salivary proteins as a preventive
measure to address dental caries.
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Chapter 2

2

A pH-sensitive Delivery System for the Prevention of
Dental Caries Using Salivary Proteins

2.1 Introduction
Saliva is a complex fluid composed of proteins, enzymes, and a variety of
electrolytes. Many physiological functions, such as chewing, initial digestion of food,
wetting and lubrication are regulated by saliva (Humphrey and Williamson 2001; Siqueira
and Dawes 2011). It also plays an active role in oral homeostasis, including partial
protection against microbial activities, the maintenance of both salivary pH and tooth
integrity (Mandel 1987). The concentration of proteins present in the saliva can be used as
an indicator to monitor oral health, as the severity and occurrence of oral diseases have
been associated with composition and quantitative changes in salivary proteins (Scarano et
al. 2010). Many of the salivary proteins are active in the regulation of tooth homeostasis,
either by directly exerting antimicrobial effects or interference in regard to microbial
colonization. Examples include statherin, histatins (HTNs), defensins, lactoferrin and
mucin (Hemadi et al. 2017) .
In particular, the HTN are of great interest because these proteins are
multifunctional. They have demonstrated biological functions including the inhibition of
calcium and phosphate precipitation on enamel and antimicrobial activities which are
directly related to the regulation of oral homeostasis (Oppenheim et al. 2007; Siqueira et
al. 2010; Siqueira et al. 2012). The HTNs mainly consist of HTN1, HTN3, and HTN5,
which have molecular weights of 4929, 4063, and 3037 Dalton respectively. Each supplies
about 20-30% of the total HTN pool (Gusman et al. 2004). HTN1 is the only
phosphorylated HTN (McDonald et al. 2011) and previous studies have demonstrated its
effectiveness in reducing bacterial colonization on tooth surfaces (Shimotoyodome et al.
2006; Vitorino et al. 2008). HTN5 has the most potent antifungal activity against Candida
albicans, which is a pathogenic yeast (Puri and Edgerton 2014). HTN3 was demonstrated
to be the most effective in killing against Streptococcus mutans (S. mutans) (Basiri et al.
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2017), which is commonly found in the oral cavity and is a significant contributor towards
dental caries.
These proteins are often present in low concentrations (Fábián et al. 2012) inside
the oral cavity due to the high proteolytic activity of saliva (Helmerhorst et al. 2006).
Therefore, we proposed a delivery system to load and protect these proteins for their use
as inhibitors of tooth decay. The use of stimulus-responsive polymeric nanoparticles
synthesized from natural polymers has recently gained substantial attention, as such smart
delivery systems have the potential to improve the overall colloidal stability of the loaded
molecules and modulate pharmacokinetics, often resulting in reduced toxicity and
enhanced efficacy (Mihu et al. 2010; Yang et al. 2010; Shen et al. 2012; Xiong et al. 2012).
The loaded cargo can be released in a stimulus-responsive manner. Examples of stimuli
include changes in pH, ionic strength, temperature, UV light, magnetic field or the presence
of specific biological molecules (Lee et al. 2003; Basel et al. 2011; Chen et al. 2014; Fan
and Gillies 2017). In particular, for applications involving the delivery of drugs to the oral
cavity. It would be ideal for the delivery system to remain stable at physiological salivary
pH and selectively release the loaded cargo under acidic conditions. The pH-responsive
property is crucial because the oral environment acidifies following carbohydrate intake,
as a result of the consumption of food and beverages. These are the conditions which
promote major oral disorders such as dental caries and dental erosion (Nikaido et al. 2004).
Many polymer-based materials have been studied for applications in controlled
drug delivery, including naturally-occurring biopolymers. For instance, chitosan is a
copolymer composed of N-acetyl-D-glucosamine and β(1-4) linked D-glucosamine (Dash
et al. 2011). It is mainly obtained through the deacetylation of chitin under alkaline
conditions (Raafat and Sahl 2009). Chitin is a biopolymer found in the exoskeletons of
crustaceans, insects, and some fungi. (Tang et al. 2015). As the only known naturally
occurring polycationic polysaccharide and with its ability to interact with anionic
molecules, chitosan and its derivatives have been studied extensively for applications in
the agricultural, medicinal and pharmaceutical industries (Souza et al. 2014; Bugnicourt
and Ladavière 2016; Olivera et al. 2016).
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Previous studies have utilized chitosan in toothpaste as an antimicrobial agent due
to its broad antimicrobial spectrum, covering both Gram-negative and Gram-positive
bacteria as well as fungi (Carvalho and Lussi 2014; Costa et al. 2014). Aside from its
antimicrobial effect, chitosan also offers other advantages including biodegradability
(Kean and Thanou 2010) and biocompatibility (Thandapani et al. 2017). It also exhibits
pH-dependent solubility due to the presence of amino groups on the polymer chains (Cha
et al. 2006). The functional amino groups can serve as platforms for interactions with other
anionic molecules to form nanoparticles, where the choice of anionic molecules depends
on the intended applications. The resulting nanoparticles should have small particle
diameters (~200 nm) to ensure a high surface area to volume ratio. Size distribution, also
known as the polydispersity index (PDI) of the nanoparticles should also be minimized (<
0.3) to obtain a uniform size distribution. Colloidal stability is equally as important, and it
is directly related to the surface charge (zeta potential) of the nanoparticles. These
parameters will be measured by dynamic light scattering (DLS), which measures the
Brownian motion of small particles in suspension and relates it to the size of the particles.
The particles will be illuminated by a laser and the intensity fluctuations in the scattered
light will be analyzed to determine particle size.
In the current work, we propose pH-sensitive chitosan nanoparticles (CNs) for
salivary proteins delivery. We hypothesized that salivary protein-loaded CNs can i)
selectively release the loaded proteins under low pH environments, ii) offer protection
against proteolysis at the physiological salivary pH, and iii) reduce S. mutans biofilm
formation on hydroxyapatite. To test these hypotheses, HTN3 was selected as the target
protein, and our objectives were to: 1) optimize CN formulation via ionic gelation with
four different types of chitosan polymers; 2) characterize both blank and HTN3-loaded
CNs; 3) quantify loading and release profiles of HTN3; 4) assess the protection offered by
loading against enzymatic degradation in 10-fold diluted human saliva; 5) evaluate the
effectiveness of HTN3-loaded CNs in reducing S. mutans biofilm formation on
hydroxyapatite discs.
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2.2 Materials and Methods
Materials
Ultra-low molecular weight (MW) chitosan and low MW chitosan (2) were purchased from
Glentham Life Sciences (Corsham, UK). The other low MW chitosan (1), medium MW
chitosan, and ZipTip C18 pipette tips were acquired from Millipore Sigma (Oakville, ON).
All filters, including Acrodisc 0.45 and 0.2 µm syringe filters with Supor Membrane and
10k Dalton Nanosep filters were purchased from Pall Corporation (Mississauga, ON).
HTN3 was acquired from Synpeptide Co., Ltd. (Shanghai, China). S. mutans UA159 was
kindly donated by the University of Toronto (Toronto, ON). Hydroxyapatite discs with 5
mm diameter and 2 mm thickness were obtained from Clarkson Chromatography Products
Inc. (South Williamsport, PA). Bicinchoninic acid assay kit was acquired from Thermo
Fisher Scientific (Mississauga, ON). All other chemicals, including sodium
tripolyphosphate (TPP), were purchased from Millipore Sigma (Oakville, ON).
Table 2.1 Summary of different types of chitosan polymers.

Type

MW (Dalton)

Degree of Deacetylation

Medium

190,000 – 310,000

75 – 85%

Low (2)

250,000 (Average)

91%

Low (1)

50,000 – 190,000

75 – 85%

Ultra-Low

20,000 (Average)

91%
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Optimized CNs Preparation
Unloaded CNs. CNs were prepared by a modified version of the ionic gelation procedure
described previously (Calvo et al. 1997). Preliminary work that studied the effect of
chitosan molar mass and degree of acetylation (Table 2.1), pH of chitosan/TPP solutions,
and chitosan to TPP ratios on CN characteristics was performed to optimize CN synthesis
as follows. 100 mg of ultra-low MW chitosan was dissolved in 100 mL of 0.4% v/v
concentrated HCl. The pH of the chitosan solution was adjusted to 5.9 with 1 M NaOH,
then filtered using a 0.45 µm syringe filter. 100 mg of TPP was dissolved in 100 mL of
Millipore water, its pH was adjusted to 6.0 and it was filtered through a 0.22 µm syringe
filter. 0.36 mL of TPP solution was added dropwise into 2.5 mL of chitosan solution under
constant stirring at 700 rpm, such that the mass ratio of chitosan to TPP is 6.94:1.

Preparation of HTN3-loaded CNs. HTN3 was mixed with chitosan solution before ionic
gelation with TPP. 0.29 mL of the 0.1% w/v TPP solution was introduced dropwise into 2
mL of 0.1% w/v chitosan and 0.0025% w/v HTN3 under constant stirring at 700 rpm. The
loading ratio of chitosan to HTN3 by mass was 40:1, and 0.45 mL of the suspension
contained 10 μg of HTN3. HTN3 loading ratios could be changed to load more or less
HTN3 as needed. Each preparation was performed in triplicate.

Characterizations of CNs
DLS. Particle diameter, PDI and zeta potential were measured by DLS (Smoluchowski
equation, wavelength of 630 nm at 25°C) using a Malvern Zetasizer Nano ZS instrument
(Malvern Instruments Ltd, Malvern UK). 1 mL of the CNs suspension was loaded into a
disposable polystyrene cuvette for particle size and polydispersity index measurement.
0.75 mL of the same suspension was injected into a folded capillary cell for zeta potential
measurement. Measurements were performed in triplicate.

Transmission electron microscopy (TEM). The morphology of the CNs was visualized
by TEM with the Philips CM10 (Philips, Amsterdam, Netherlands) at 80 kV. To remove
salts, 3 mL of the CNs suspension was loaded into a 50 kg/mol MW cut-off regenerated
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cellulose dialysis tubing (Spectrum Labs, New Brunswick, NJ) and dialyzed in 1 L of
deionized water for 3 hours under constant stirring. TEM samples were prepared by placing
one drop of the dialyzed CNs suspension onto the Formvarâ-coated copper grid, and the
sample was dried overnight under an air atmosphere. Images were captured in triplicate.

pH-dependent swelling. To investigate the pH-dependence of CN size, initial particle
size measurements were taken at a starting pH of 6.3 (time = 0 minutes). The pH of the
suspension was then adjusted to different pH values: 3, 4 and 5 directly with 1 M HCl.
After the pH adjustments, particle size, PDI and zeta potential were observed by DLS at
10, 20, 30, 60, 120, and 240 minutes in triplicate at each pH value. The CNs were not resuspended in buffers due to possibility of salt accumulation.

Stability. CNs were stored at 4°C for 61 days to evaluate colloidal stability. Particle size
and zeta potential were measured by DLS on days 1, 10, 15, 22, 30, 35, 45, 52, and 61 in
triplicate.

Loading and Release of HTN3
pH-dependent release study. 0.05 mL of pH 6.8, 25 mM phosphate buffer/500 mM NaCl
solution was added to 0.45 mL of HTN3-loaded CNs. The 0.5 mL suspension was then
centrifuged at 14462 g for 10 minutes using a 10 kg/mol cut-off Nanosep filter. Only the
free HTN3 (4063 Dalton) is small enough to pass through the filter. The filtrate was
collected to determine loading efficiency by gel electrophoresis. The pH of the retentate on
top of the filter was adjusted to pH 3, 4, or 5 using 1 M HCl and incubated at 37°C for 30
minutes. The suspension was centrifuged again, allowing the passage of released HTN3
through the filter. Subsequently, the filtrate was collected to determine the extent of protein
release. Both loading and release filtrates, and a HTN3 standard of 5 μg were vacuum dried.
The release study was performed in triplicate.

Cationic polyacrylamide gel electrophoresis (PAGE). Cationic-PAGE was performed
as previously described (Siqueira et al. 2010). Lyophilized samples were dissolved in
sample loading buffer composed of 0.04% w/v methyl green and 20% w/v sucrose.
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Electrophoresis separation was performed at a constant voltage of 120 V. Subsequently,
the gels were stained overnight with 0.1% w/v coomassie-blue dye in 7% v/v acetic acid
and 8% v/v methanol. The following day, the gels were de-stained with 40% v/v methanol
and 10% v/v acetic acid.

Loading Efficiency. HTN3-loaded CNs with 2%, 5%, and 10% w/w (HTN3 to chitosan)
loading ratios were prepared as previously described with modifications to the mass ratio
of chitosan to HTN3. 0.05 mL of pH 6.8, 25 mM phosphate buffer/500 mM NaCl solution
was added to 0.45 mL of HTN3-loaded CNs at each loading ratio. The 0.5 mL suspension
was then centrifuged at 14462 g for 10 minutes using a 10,000 g/mol cut-off Nanosep filter.
Since the un-loaded HTN3 (4063 Dalton) is small enough to pass through the filter, the
filtrate could be used to calculate loading efficiency. The filtrate was collected, and vacuum
dried together with a HTN3 standard of 5 μg for use as control. Cationic-PAGE was
performed as described previously. The loading efficiency was determined by Image Lab
(BioRad) via relative quantity tool. The relative quantity is the ratio of the band volume
and intensity divided by the reference band volume and intensity. A HTN3 standard band
was set as the reference and the other bands were compared against the reference band.
The loading experiment was performed in triplicate for each loading ratio.

Cumulative Release. HTN3-loaded CNs were prepared as previously described. 0.05 mL
of pH 6.8, 25 mM phosphate buffer/500 mM NaCl solution was added to 0.45 mL of
HTN3-loaded CNs. The 0.5 mL suspension was then centrifuged at 14462 g for 10 minutes
using a 10 kg/mol cut-off Nanosep filter. Retentate on top of the filter was kept constant at
6.8 or adjusted to pH 3, 4, or 5 using 1 M HCl, then incubated at 37°C for 30 minutes. It
was then subjected to centrifugal ultrafiltration at 14462 g for 10 minutes to separate the
released protein. Subsequently, the filtrate was collected. The retentate was replenished
back to 0.5 mL with the buffer at the same pH. The filtrate and a HTN3 standard of 5 μg
were analyzed by PAGE as previously described. The separation and quantification of
released protein was repeated at 30, 60, 90, 120, 150, 180, and 210 minutes. Cumulative
release was performed in triplicate at each pH value.
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pH Cycling Release. pH of HTN3-loaded CNs was cycled between pH 4 and 6.8 to reflect
pH changes in the oral cavity. 0.05 mL of pH 6.8, 25 mM phosphate buffer/500 mM NaCl
solution was added to 0.45 mL of HTN3-loaded CNs. The 0.5 mL suspension was then
centrifuged at 14462 g for 10 minutes using a 10 kg/mol cut-off Nanosep filter. The
remaining retentate on top of the filter was adjusted to pH 4 with 1 M HCl and subjected
to centrifugal ultrafiltration at 14462 g for 10 minutes to separate the released protein. The
filtrate was collected and the retentate was replenished with pH 6.8 buffer to a volume of
0.5 mL. The pH cycling release followed the adjustments order of pH 4, 6.8, 4, 6.8, 4, 6.8,
4. Cationic-PAGE was performed on all filtrates and a HTN3 standard of 5 μg as previously
described. pH cycling was performed in triplicate.

Protein Degradation Study
Saliva Collection. Whole saliva samples were collected 2 hours after breakfast between
9:00 am to 11:00 am to minimize the effect of circadian rhythm. Samples included 3
healthy participants ranging from 24 to 32 years old. Stimulated whole saliva was obtained
by masticating on a piece of parafilm. 3 to 5 mL of saliva was collected on ice. Immediately
after collection, whole saliva samples were centrifuged for 10 minutes at 14462 g at 4 °C
to separate the bacteria, cells and other debris. The supernatant is referred to as whole saliva
supernatant (WSS). Salivary proteins were quantified using a bicinchoninic acid assay kit.

Degradation of Free HTN3 in WSS. The degradation experiments were carried out in
10-fold diluted WSS. 50 μg of free HTN3 was added to diluted WSS (100 mg salivary
protein/mL) in a final volume of 1 mL. The pH was adjusted to 6.8 using 1 M HCl or 1 M
NaOH, depending on the pH of collected saliva. An aliquot of 100 μL was collected and
boiled for 5 minutes to terminate proteolytic activity after incubation at 37 °C for 0, 0.5, 1,
2, 3 or 6 hours. Samples were dried and desalted. Cationic-PAGE was performed to study
the degradation samples. The extent of degradation was quantified by Image Lab using the
relative quantity tool.
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Degradation of HTN3-loaded CNs in WSS. The degradation experiments were carried
out with 10-fold diluted WSS. 0.5 mL of the HTN3-loaded CNs (containing 50 μg of
HTN3) was added to diluted WSS (100 mg salivary protein/mL) to reach a final volume of
1 mL. The final pH was standardized to 6.8 with 1 M HCl or 1 M NaOH, depending on the
initial pH of saliva. An aliquot of 100μL was collected after incubation at 37°C at the
following time points: 0, 0.5, 1, 2, 3 and 6 hours. The pH was adjusted to 3 to release all
of the HTN3 within the delivery system. After centrifugation with a 10,000 g/mol Nanosep
filter, the filtrate was retrieved and boiled for 5 minutes to terminate proteolytic activity.
Samples were dried and desalted, followed by Cationic-PAGE. The extent of degradation
was quantified by Image Lab through relative quantity tool. Each degradation study was
performed in triplicate.

S. mutans Killing Assay and Biofilm Formation
S. mutans Growth. 10 colonies of S. mutans (UA 159) were grown for 14 hours in 10 mL
of Tryptone Yeast Extract Broth (TYEB) supplemented with 1% glucose at 37 °C and 10%
CO2. After incubation, the bacterial suspension was washed with 0.9% NaCl twice and the
supernatant was discarded after each wash. The pellet was resuspended in 1.2 mL of
phosphate-buffered saline (PBS). 0.8 mL of the suspension were used for optical density
(OD) measurement at 600 nm, then diluted with PBS if needed to obtain a reading of
approximately 1.5, corresponding to the bacterial concentration of 109 colon forming units
(CFU)/mL based on the calibration curve.

Killing Assay. From the suspension with 1.5 OD reading, 0.1 mL was added to 9.9 mL of
PBS to obtain a bacterial concentration of 107 CFU/mL. 50 μL of the 107 CFU/mL
suspension was added to an equal volume of a serial dilution series of HTN3 in a 96-well
polypropylene microtiter plate. The samples were then incubated at 37 °C for 1.5 hours.
After incubation, each sample was diluted 103 and 104-fold in PBS, and 20 μL of each
dilution was plated onto Todd Hewitt Broth (THB) agar plates. Bacterial viability was
assessed by colony counting using comparisons against control samples incubated without

34

HTN3. The IC50 value was calculated based on the dose-response curve. The killing assay
was performed in triplicate.

S. mutans Biofilm Formation on Hydroxyapatite Discs. Hydroxyapatite discs were
fixed on the interior of a 24-well polypropylene microtiter plate cover, where the discs
were carefully positioned so that the plate cover fits both 24 and 96-well plates. The plate
cover was placed to immerse all discs in a 96-well plate filled with 200 μL of 5 different
treatment solutions: control (PBS), 0.03 mg/ mL HTN3, 0.1% w/v unloaded CNs, 0.1%
w/v CNs containing 6 μg of loaded HTN3, and 12300 ppm fluoride solution for two hours.
Three discs were assessed per treatment group. Subsequently, the plate cover was placed
on a 24-well plate with 2 mL of 0.9% w/v NaCl to wash the discs. Afterwards the discs
were immersed into 2 mL of TYEB supplemented with 1% w/v glucose and 107 CFU/mL
of bacteria. The discs were then incubated at 37°C in 10% CO2 for 8 hours. After
incubation, the discs were washed again with NaCl, followed by further incubation for 16
hours immersed in 2 mL of TYEB supplemented with 0.1 mM glucose. Over the next 4
days, the discs were incubated in a repeating cycle between solution 1 and 2 where solution
1 is TYEB supplemented with 1% w/v sucrose for 8 hours, and solution 2 is TYEB
supplemented with 0.1 mM glucose for 16 hours. On the 6th day, all discs were transferred
to separate tubes filled with 1 mL of PBS, followed by sonication to remove the biofilms
off the discs. 0.5 mL of the suspension was transferred to pre-weighed tubes and
centrifuged at 14400 g for 5 minutes. The supernatant was removed, and the weight of wet
biofilm was measured. The same suspension was diluted 106 and 107 times in PBS, and 20
μL of each dilution was plated onto THB agar plates. Bacterial viability was assessed by
colony counting. This experiment was performed with a sample size of 6.

Statistical Analyses
Statistical analyses were performed using software Prism 7.0 GraphPad. Biofilm mass and
bacterial viability were analyzed by ordinary one-way ANOVA followed by Tukey’s
multiple comparisons test between each treatment group. The level of significance (α) was
set at 0.05 (95% confidence interval).
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2.3 Results
2.3.1

Optimization of CN Formulation
Chitosan samples with different MWs and degrees of acetylation were investigated

initially to determine which would provide the best particles. We sought a diameter of less
than 200 nm, a zeta potential of > 15 mV to afford colloidal stability, and a low
polydispersity index of < 0.3 to have well-defined materials.

Medium MW. The effect of chitosan to TPP mass ratio was studied by varying the
mass ratio from 3.5:1 to 10:1. The particle diameter decreased up to a ratio of 3.7:1, then
increased (Figure 2.1a). The PDI followed a similar trend with an initial decrease in PDI
up to 3.7:1 chitosan:TPP, followed by an increase at higher ratios (Figure 2.1b). Lastly, as
shown on Figure 2.1c, zeta potential increased steadily with a corresponding increase in
chitosan to TPP ratio. This was expected due to increased cationic polymer presence in the
CNs. Taking all three parameters into consideration, the optimal formulation for medium
MW chitosan was at the mass ratio of 4.17:1 (chitosan:TPP). Nanoparticles at this ratio
had a diameter of 188 ± 2 nm in diameter, a PDI of 0.275 ± 0.007, and a zeta potential of
18 ± 3 mV.

Low MW (1). Similar trends were observed in low MW chitosan (1). Particle
diameter and PDI continued to decrease with an increase in chitosan:TPP mass ratio until
5:1. Zeta potential increased as chitosan:TPP increased due to increased cationic polymer
presence. The optimum formulation was chosen at 5.88:1 chitosan to TPP with a size of
160 ± 10 nm in diameter, a PDI of 0.28 ± 0.01, and a zeta potential of 17.9 ± 0.5 mV.

Low MW (2). Similar to the previous chitosan polymers, low MW (2) chitosan
demonstrated the same trend. Particle diameter and PDI continued to decrease with a
corresponding increase in chitosan:TPP until the ratio of 6.94:1. Zeta potential increased
steadily as chitosan:TPP increased because of the presence of increased amount of cationic
chitosan. The optimal ratio was selected at 6.94:1 chitosan to TPP. At this ratio, the
resulting nanoparticles had a diameter of 320 ± 16 nm, a PDI of 0.39 ± 0.02, and a zeta
potential of 23 ± 1 mV.

36

Figure 2.1 The effect of chitosan to TPP ratio on a) Z-average diameter. The particle
diameter decreased when the ratio was increased until a certain threshold, beyond
which particle diameter steadily increased. b) PDI followed a similar trend as particle
diameter. c) Zeta potential increased with increasing chitosan:TPP ratio. Error bars
correspond to the standard deviations of triplicate samples.

Ultra-low MW. Because of the lower MW and the higher degree of deacetylation,
ultra-low MW chitosan was able to form nanoparticles across a wide range of chitosan to
TPP mass ratios with similar particle diameters and PDI values. The optimal ratio was
selected at 6.94:1 chitosan to TPP. At this ratio the nanoparticles had a diameter of 144 ±
6 nm, a PDI of 0.15 ± 0.04, and a zeta potential of 18 ± 4 mV. Ultra-low CNs were selected
as the optimal formulation based on smallest particle diameter and lowest PDI at a
relatively stable zeta potential.
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2.3.2

Characterization of Unloaded and HTN3-loaded CNs by DLS
The CNs prepared from ultra-low MW chitosan were characterized by DLS. The

unloaded CNs had a Z-average diameter of 144 ± 6 nm, a PDI of 0.15 ± 0.04, and a zeta
potential of 18 ± 4 mV at pH 6.3, the pH of the initially prepared particle suspension. The
protein of interest, HTN3, was loaded into the CNs at various loading ratios (Table 2.2).
The HTN3-loaded particles had similar diameters, PDI, and zeta potential to the unloaded
particles. Figure 2.2 shows the volume distribution of the HTN3-loaded CNs at pH 6.3 and
at pH 3. At pH 3, the Z-average diameter increased to 260 nm, showing the pH-responsive
swelling behavior of the CNs.
Table 2.2 DLS data for unloaded and HTN3-loaded CNs prepared from ultra-low MW
chitosan. Error bars correspond to the standard deviations of triplicate samples.

Protein Loading Ratio (w/w%)

Z-Avg Diameter (nm)

PDI

Zeta (mV)

0 (unloaded)

144 ± 6

0.15 ± 0.04

18 ± 4

2

142 ± 6

0.16 ± 0.05

18 ± 2

5

134 ± 7

0.15 ± 0.03

19 ± 3

10

136 ± 6

0.16 ± 0.04

20 ± 3

Figure 2.2 DLS volume distribution of blank CNs at pH 3 and pH 6.3 showing a
representative increase in diameter at acidic pH due to swelling.
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2.3.3

TEM Images of Unloaded and HTN3-loaded CNs
The CNs were then visualized with TEM. As shown in Figure 2.3, the CNs had a

spherical morphology, and the observed diameters were in reasonable agreement with the
data obtained from DLS.

Figure 2.3 TEM images of CNs: a) Unloaded; b) HTN3-loaded at a 2% w/w loading
ratio; c) HTN3-loaded at a 5% w/w loading ratio; d) HTN3-loaded at a 10% w/w
loading ratio. The particles appeared spherical and the diameters were in reasonable
agreement with the DLS results.
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2.3.4

Stability of Unloaded CNs
The unloaded CNs were stored at 4 °C and DLS measurements were taken routinely

over the course of 61 days. On day 1, the CNs had a particle diameter of 143 ± 4 nm, a
PDI of 0.16 ± 0.02 at a zeta potential of 17.4 ± 0.4 mV. On day 61, they had a Z-average
diameter of 152 ± 4 nm, a PDI of 0.16 ± 0.02 at a zeta potential of 17 ± 2 mV (Figure 2.4).
These results indicate that the CNs are stable for at least 2 months when stored at 4°C.

Figure 2.4 DLS data for CNs stored at 4°C for 61 days: a) Z-average diameter; b)
PDI; c) Zeta potential. No changes were observed, suggesting that the nanoparticles
are stable under these conditions. Error bars correspond to the standard deviations
of triplicate samples. Some error bars are too small to be seen because the standard
deviations are smaller than the data points.)
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2.3.5

pH-dependent Swelling CNs
The pH-responsive properties of the unloaded CNs were examined first by

adjusting the pH from the initial pH of 6.3 for the formulation to pH 3, 4, or 5. DLS
measurements of the Z-average diameters at each pH indicated greater swelling at lower
pH values (Figure 2.5a). The CNs swelled from 146 nm to 260 nm at pH 3. The swelling
was rapid at each pH, reaching an equilibrium diameter at 10 minutes. We also subjected
the CNs suspension to pH cycling between 6.3 to 4. Measurements of the Z-average
diameter suggested that the CNs were able to selectively swell under acidic conditions and
then to contract when the pH was increased upon removal of the stimulus (Figure 2.5b).
However, there was a general trend towards larger diameters with repeated swelling cycles.

Figure 2.5 pH-responsive behavior of the CNs: a) Z-average diameters over time at
different pH values from 3 to 6.3. The results suggest the degree of swelling is
proportional to the acidity of the suspension. The swelling behavior was also rapid,
and reached equilibrium 10 minutes after pH adjustment. b) The pH-responsive
behavior was further examined through pH cycling between pH 6.3 and 4 at a 10minute interval. The CNs were able to swell and contract accordingly based on the
suspension pH. Error bars correspond to the standard deviations of triplicate
samples.
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2.3.6

Loading Efficiency
The protein of interest, HTN3 was loaded into CNs at three different loadings: 2,

5, and 10% w/w and after separation of the un-loaded protein by centrifugal ultrafiltration,
it was quantified by Cationic-PAGE. The absence of protein bands shown on Figure 2.6
suggested that all of the HTN3 was successfully loaded into the CNs at each loading ratio.

Figure 2.6 Loading ratios of 2%, 5%, and 10% w/w HTN3 to chitosan were
investigated. The absence of the protein bands in the representative gel after isolation
of unloaded protein by centrifugal ultrafiltration suggests the protein at each loading
ratio was fully loaded into the nanoparticles. The experiment was repeated in
triplicate.

2.3.7

pH-dependent Release of HTN3 from CNs
The release kinetics of HTN3-loaded CNs were investigated at different pH values

over a period of 210 minutes, with protein release measured every 30 minutes. Figure 2.7a
shows the Cationic-PAGE for the cumulative release at pH 3. For this particular experiment
the CNs released ~90% of the loaded HTN3 over the 7 time points (210 minutes). pH
cycling was also performed to reflect the pH changes that happen many times in the oral
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cavity throughout the day. HTN3 loaded CNs were subjected to pH treatments in the
following sequence: 6.8, 4, 6.8, 4, 6.8, 4, 6.8, and 4. After isolation of released protein and
Cationic-PAGE at each pH change, protein bands of HTN3 were only observed at pH 4
and were absent at pH 6.8 (Figure 2.7b). This result shows the pH selective release for the
CNs.
a)

b)

Figure 2.7 The cumulative and pH cycling release of HTN3-loaded CNs were
investigated under different pH conditions with released protein displayed using
Cationic-PAGE (representative example shown). a) Cumulative release at pH 3 over
7 time points obtained at 30-minute intervals. b) pH cycling from pH 4 to pH 6.8 at
30-minute intervals, showing that the CNs selectively released the loaded protein at
pH 4 but not at 6.8. The experiment was repeated in triplicate.
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The cumulative release experiment was repeated at pH 4, 5, and 6.8, the results
were quantified using Image Lab and plotted in Figure 2.8a. The highest cumulative
amount of HTN3 release was observed at pH 3, and there was minimal release at pH 6.8.
On average, at pH 3, the CNs were able to release ~84 ± 7% of the loaded HTN3, ~58 ±
9% at pH 4, ~36 ± 3% at pH 5, and ~2 ± 2% at pH 6.8 over 7 separate releases. The pH
cycling release was also quantified and presented in Figure 2.8b. The CNs were able to
respond to the environmental pH changes and release the protein selectively at acidic pH.

Figure 2.8 a) Release of HTN3 from CNs at different pH values were quantified using
Image Lab. The highest extent of release and most rapid release was observed at pH
3, and there was minimal release at pH 6.8. On average, at pH 3, the CNs were able
to release ~84 ± 7% of the loaded HTN3, ~58 ± 9% at pH 4, ~36 ± 3% at pH 5, and ~2
± 2% at pH 6.8. b) pH cycling release at 30-minute intervals between pH 6.8 and 4
show that the CNs can adapt to environmental pH changes and release HTN3
selectively at pH 4 over 3 pH cycles. Error bars correspond to the standard deviations
on triplicate samples.
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2.3.8

HTN3 Degradation Study in WSS
In order to assess the protection offered through loading against enzymatic

degradation in the oral cavity, a protein degradation study was conducted in 10-fold diluted
human saliva to compare the degradation kinetics of free HTN3 and HTN3 loaded CNs.
Figure 2.9a shows Cationic-PAGE for free HTN3 at different time points in contact with
WSS. Figure 2.9b shows the Cationic-PAGE for HTN3 loaded into CNs. The protein bands
of free HTN3 disappeared more rapidly, suggesting faster degradation without the
protection offered by CNs.
a)

b)

Figure 2.9 Protein degradation in WSS, evaluated by Cationic-PAGE (representative
example shown, N = 3): a) free HTN3 and b) HTN3 loaded CNs. Most of the protein
was degraded at the 2-hour mark for the control group, supported by the faded
protein bands of HTN3. At the same time point, the protein band of HTN3 loaded
within CNs remained relatively strong.
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The degradation over time was quantified for both free HTN3 and HTN3 loaded
CNs (Figure 2.10). For free HTN3, only 6 ± 5 % of the free HTN3 remained after 2 hours,
whereas 47 ± 8 % of HTN3 was intact when it was loaded in the CNs delivery system.
Protection provided by the CNs were plotted as the difference in degradation kinetic
between free HTN3 and HTN3-loaded CNs.

Figure 2.10 Protein degradation over time for free HTN3 and HTN3-loaded into CNs.
For free HTN3, most HTN3 was degraded in 2 hours. At the same time point, about
half of HTN3 was still intact in the CNs delivery system. The dashed line represents
the protection offered by the CNs, displayed as the difference in degradation
percentage between free HTN3 and HTN3-loaded CNs. Error bars correspond to the
standard deviations on triplicate samples.
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2.3.9

S. mutans Killing Assay
To evaluate the effectiveness of HTN3 loaded CNs against biofilm formation by S.

mutans on hydroxyapatite discs, the amount of HTN3 required to be loaded was first
determined from a killing assay. First, a correlation was established between absorbance at
600 nm and colony-forming unit (CFU)/mL for S. mutans, where CFU is a unit commonly
used in microbiology to estimate the number of viable bacterial cells in a given sample.
This is shown in Figure 2.11, where a linear relationship between absorbance and CFU/mL
was observed.

Absorbance (600 nm)

1.5
1.2
0.9

y = 0.003912x + 0.09995
R2 = 0.9597

0.6
0.3
0.0

0

50

100 150 200 250 300 350 400

CFU/mL (107)

Figure 2.11 Relationship between optical absorbance at 600 nm and S. mutans CFUs.
(N = 3), error bars cannot be seen because the standard deviations are smaller than
the data points)
The antibacterial effect of pure HTN3 was evaluated through a killing assay against
107 CFU of S. mutans. 107 CFU was chosen because it is the bacterial population required
to form a complete biofilm, and the IC50 was calculated to be 7.4 μM for pure HTN3 (Figure
2.12). IC50 is the concentration required to inhibit a biological process by half. The same
concentration of HTN3 was used in the CN-loaded form for subsequent experiments and
tested against biofilm formation of S. mutans.
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Figure 2.12 Killing assay results of pure HTN3 against 107 CFU S. mutans. Here, IC50
= 7.4 μM. Error bars correspond to the standard deviations on triplicate samples.
Some error bars cannot be seen because the standard deviations are smaller than the
data points (95% CI: 5.4 to 10.1 μM)

2.3.10

Biofilm Formation

Wet biofilm mass was measured to test the effectiveness of 4 different treatment
groups including 7.4 μM HTN3, 0.1% w/v unloaded CNs, 7.4 μM HTN3 in CNs, and the
gold standard 12300 ppm fluoride solution. They were compared against PBS as a control
group. As presented in Figure 2.13, the control group had an average wet biofilm mass of
16 ± 2 mg, while the mass was 12 ± 1 mg for HTN3, 8 ± 2 mg for fluoride, 6 ± 1 mg for
unloaded CNs, and 5.3 ± 0.9 for HTN3-loaded CNs.
Bacterial cell viability was also evaluated and presented in Figure 2.14. The PBS
control led to 5.25 x 109 ± 1 x 108 CFU/mL of viable bacteria, while free HTN3 had 4.7 x
109 ± 0.2 x 109 CFU/mL, fluoride had 4.0 x 109 ± 0.4 x 109 CFU/mL, unloaded CNs had
3.0 x 109 ± 0.2 x 109 CFU/mL, and HTN3-loaded CNs had 2.3 x 109 ± 0.5 x 109 CFU/mL.
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Figure 2.13 a) Wet biofilm masses for 4 treatment groups were compared against the
control group PBS. All 4 treatment groups led to significantly lower biofilm mass than
PBS. Fluoride, blank and HTN3-loaded CNs performed significantly better than free
HTN3 in minimizing biofilm formation, but no significant difference in biofilm mass
was observed between these treatment groups. Error bars correspond to the standard
deviations on 6 samples. b) Tukey’s multiple comparisons test was performed at 95%
confidence intervals. The two groups were significantly different from each other only
if the difference between group means ± upper and lower limits did not cross zero
(dotted line).
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Figure 2.14 a) Bacterial viability for the 4 treatment groups were compared against
the control group treated with PBS only. While free HTN3 did not control bacterial
growth, fluoride treatment significantly decreased bacterial growth. Blank and
HTN3-loaded CNs were the most effective at decreasing bacterial population but are
insignificantly different from each other. Error bars correspond to the standard
deviations on 6 samples. b) Tukey’s multiple comparisons test was performed at 95%
confidence intervals. The two groups were significantly different from each other only
if the difference between group means ± upper and lower limits did not cross zero
(dotted line).
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2.4 Discussion
Chitosan polymers with different properties were studied to optimize nanoparticle
formulation via ionic gelation. The mechanism behind ionic gelation involves interactions
between the positively charged chitosan polymer chains and the negatively charged crosslinking agent TPP under mechanical stirring. MWs and degrees of deacetylation were
studied in this work because these factors determine how the chitosan polymer chain
interacts with the cross-linker agent TPP (Zhang and Neau 2001; Schiffman and Schauer
2007). The degree of deacetylation determines how many deacetylated sites are available
for cross-linking, while MW regulates how accessible these deacetylated sites are.
Based on previously reported work, CNs can be prepared at various concentrations,
ranging from 0.1 – 1 mg/mL (Dudhani and Kosaraju 2010; Sullivan et al. 2018), and given
a higher concentration formulation is desirable due to greater efficacy, 1 mg/mL for both
chitosan and TPP was used for all experiments. Chitosan to TPP mass ratio was studied
extensively in an attempt to optimize the formulation. Initially, the average particle
diameter of the CNs decreased with increased chitosan to TPP ratio, which can be
explained with the increased cross-linking density between chitosan and TPP. However,
beyond a certain ratio threshold, CNs started to form aggregates. This could be due to
bridging of the nanoparticles by excess chitosan chains. The PDI also followed a similar
trend since as chitosan to TPP ratio increased, higher cross-linking density promoted a
more uniform size distribution of CNs. However, beyond the critical ratio, the CNs started
to aggregate as described above, resulting in higher PDIs. For the zeta potential, a steady
increase was observed with increasing chitosan to TPP ratios, since chitosan is positively
charged and excess chitosan leads to more cationic nanoparticles. The findings are in
agreement with many studies in the literature (Fan et al. 2012; Jonassen et al. 2012).
However, the critical ratios differed depending on the MW and degree of deaceytalation of
the chitosan polymer.
The optimal formulation was selected based on particle diameter, PDI and zeta
potential. The particle diameter is important, because smaller particles have a higher
surface to volume ratio, which can therefore adhere to the tooth surface more readily and
also swell and contract more easily (Liu et al. 2007). Secondly, PDI is another crucial index
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to characterize nanoparticles. It is a dimensionless value generated from a cumulants
analysis (2 parameter fit), scaled, and ranges from 0 to 1 for nanoparticles. Values smaller
than 0.05 are rare except for highly monodisperse standards. Values greater than 0.7
suggests the size distribution is very broad and means that DLS may not be the best
technique to analyze the sample of interest. In general, a lower PDI is better as it indicates
a more monodisperse, well-defined sample. Lastly, zeta potential exists between the
particle surface and the dispersing liquid. It measures the extent of electrostatic
repulsion/attraction between particles and provides insight into the overall stability of
nanoparticle

suspension

and

its

tendency

to

aggregate.

In

general,

highly

positively/negatively charged nanoparticles form more stable suspensions due to
electrostatic repulsions, compared to nanoparticles with zeta potentials close to zero. The
optimal formulation will have the best balance of all three parameters. Ideally, it is best to
have a formulation with a sub-200 nm nanoparticles in diameter, with a relatively low PDI
and a high zeta potential. Through a colloidal stability study by time-course of particle size
and PDI measurements by DLS, we found that the nanoparticles maintain their average
size and PDI when the zeta potential is above 15 mV. Therefore the ultra-low MW chitosan
formulation at a ratio of 6.94:1 (chitosan to TPP) was chosen as it has the smallest particle
diameter of 144 ± 6 nm, with the lowest PDI of 0.15 ± 0.04 at a zeta potential of 18 ± 4
mV. The optimized CNs were visualized by TEM and the average particle diameter
estimated from the TEM images was in good agreement with the average particle diameter
obtained from DLS. Since HTN3 is a low MW salivary protein, the loading of it into the
CNs didn’t affect the particle diameter. As shown by the TEM images, there was no general
variance in size or dispersity between the unloaded CNs and those with different HTN3
loading ratios.
The pH-responsive properties of the optimized CNs were also investigated. The
extent of swelling under different pH conditions was studied. The highest degree of
swelling was observed at pH 3 and the CNs remained unchanged at pH 6.3. The results
also demonstrated the degree of swelling was proportional to the acidity of the suspension.
The swelling response elicited by the pH stimulus was rapid, suggesting that CNs were
able to quickly respond to pH changes. The versatility of this pH-responsive property was
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further examined through pH cycling between 6.3 and 4, and the results suggested the CNs
delivery system was capable of swelling selectively at acidic pH and reversed the swelling
process upon removal of the pH stimulus.
The loading loading efficiency of HTN3 was studied at 2%, 5%, and 10% w/w
loading ratios of HTN3 to chitosan. The absence of unloaded protein suggested that HTN3
was quantitatively loaded in the delivery system at all ratios, which is beneficial, as the
loading can therefore be tuned. Cumulative release studies at different pH values including
3, 4, 5, and 6.8 were also conducted to assess the extent of release of loaded HTN3 from
the delivery system. These values were chosen because they reflect the cariogenic
conditions promoting different oral diseases. For instance, dental caries initiate at pH 5 and
dental erosion occurs at pH 3. In accordance with the demonstration of the pH-responsive
property shown previously, the extent of HTN3 release was proportionate to the acidity of
the environment. A maximum cumulative release of ~84 ± 7% was achieved at pH 3 over
7 time points, while a minimum release of ~2 ± 2% was observed at pH 6.8. In order to
better mimic the pH changes in the oral cavity throughout the day, pH cycling release was
performed between pH 6.8 and 4. As presented in the results section, HTN3-loaded CNs
were able to selectively release loaded HTN3 at pH 4, and retain the HTN3 at the salivary
pH of 6.8. The ability to selectively release HTN3 under acidic conditions is crucial
because throughout the day the salivary pH fluctuates many times from the consumption
of food or beverages (Bowen 2013). As saliva becomes acidic following carbohydrate
intake, the drop in pH could trigger the release of HTN3, which promotes oral homeostasis
by inhibiting the demineralization process. Salivary pH would gradually recover to its
physiological value due to the buffer capacity of saliva, which would halt HTN3 release
from the CNs. Further release of HTN3 would require another incident of sugar ingestion,
which would drop salivary pH.
Salivary proteins are known to be susceptible to the high proteolytic activity in the
oral cavity, which prevent them from being utilized as potential therapeutics on their own.
To evaluate the protection offered by CN against enzymatic degradation, a protein
degradation study was performed in 10-fold diluted human saliva. Saliva was diluted to
better capture the degradation kinetics of proteins, since at the original concentration the
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degradation would have happened too rapidly to allow easy measurement of the process.
As presented in the results section, only 6 ± 5 % of the free HTN3 remained at the 2-hour
mark. At the same time point, about 47 ± 8 % of HTN3 was still present in the CN delivery
system. At the 6-hour mark, only 7 ± 1 % of HTN3 remained in the delivery system, which
could be due to the potential breakdown of the CNs by amaylase. Nevertheless, the delivery
system prolonged the protein survival time by two-fold. The increase in survival time is
important because it allows less frequent administration of the formulation.
Ultimately, a biofilm model was applied to evaluate the therapeutic effect of HTN3loaded CNs against S. mutans biofilm formation on hydroxyapatite discs. S. mutans was
chosen because it is a major contributor responsible for the initiation and development of
tooth decay (Garcia et al. 2017). It metabolizes sucrose to produce sticky polysaccharides
which allow the bacteria to aggregate and adhere to the tooth enamel, forming a biofilm.
The biofilm, together with frequent sugar intake promotes fermentation of dietary sugar
into acidic products. Persistence of the resulting acidic conditions favors the proliferation
of acidogenic bacteria. The low pH environment in the biofilm initiates the dental caries
process (Argimón and Caufield 2011). Hydroxyapatite is a mineral composed of calcium
phosphate, which greatly resembles human hard tissues including bone and tooth enamel
in composition and morphology (Wei and Ma 2004). It is also the most stable calcium
phosphate mineral under physiological conditions (Kalita et al. 2007). Therefore it has been
extensively used in oral applications, such as pellicle formation and biofilm formation
(Vacca Smith and Bowen 2000; Takeshita et al. 2015).
Two key factors used to evaluate biofilm growth are biofilm mass and bacterial cell
viability. Effective treatment should result in low biofilm mass and reduced bacterial cell
viability. For biofilm mass measurements, based on the ANOVA analysis and Tukey’s
multiple comparisons test, all four treatment groups resulted in significant lighter biofilms
than the control group. Fluoride, together with unloaded and HTN3-loaded CNs were
significantly more effective than free HTN3. However, no significant difference was
observed between the treatment groups. These treatment groups successfully lowered the
biofilm mass by at least half. Bacterial cell viability was also determined for all treatment
groups. Free HTN3 was not effective at reducing bacterial cell viability and did not perform
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better than the control group. Fluoride, unloaded, and HTN3-loaded CNs significantly
reduced cell viability when compared against the control group. However, when compared
against HTN3, fluoride was not significantly more effective, even though it is significantly
more effective than the control group. Unloaded and HTN3-loaded CNs were the most
competent treatment groups. They reduced cell viability in half, but their performance in
reducing bacterial population were not significantly different from one another. These
results suggest that CNs alone can potentially reduce biofilm growth, which could be
explained with the functional amino group attacking the cell wall of S.mutans. This opens
up the possibility of integrating blank CNs directly into dental hygiene products such as
mouth wash to prevent dental caries. However, toxicity of these CNs still needs to be
determined.

Even though HTN3-loaded CNs didn’t outperform blank CNs as

hypothesized, it is still worth investigating with the optimization of current biofilm model.
Future studies can load greater amount of HTN3, or reduce the amount of CNs while
maintaining HTN3 concentrations. In addition, CNs are known to exhibit antimicrobial
effects against S.mutans (Chávez de Paz et al. 2011). Another possible explanation would
be CNs alone already prevented the initiation of demineralization, therefore there was no
steep drop in pH to trigger HTN3 release from the CNs.
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2.5 Conclusion
The results of this study have demonstrated the pH-responsive property of the CNs.
The CNs were also able to offer protection against enzymatic degradation in comparison
to free HTN3. While HTN3-loaded CNs had successfully reduced biofilm growth as
reflected by reduced biofilm mass and bacterial cell viability, it did not significantly
outperform unloaded CNs. Future studies should include using the biofilm model to
characterize the contribution of HTN3 within CNs and CNs alone in controlling bacterial
population. Nonetheless, this work has shown that CNs can be utilized as a protein carrier
for oral applications, especially for complications involving acidic environments. This
delivery system can also be applied to load other salivary proteins for oral delivery. For
instance, HTN1 and HTN5 can be readily loaded into the CNs as they share similar
properties as HTN3. Anionic proteins can also be loaded into the CNs with a modified
loading protocol. The ultimate goal of this project is to develop a formulation which could
be integrated into daily dental hygiene products like toothpaste and mouthwash to provide
a preventative approach to address dental caries. Even though blank CNs have
demonstrated the potential at reducing biofilm growth, multifunctional salivary proteinsloaded HTN3 is still worth investigating. The results presented in this chapter show that a
pH-sensitive delivery system that can release salivary proteins under acidic conditions can
be achieved by utilizing a biodegradable, biocompatible, and naturally-derived polymer
like chitosan.
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Chapter 3

3

Conclusions and Future Work

3.1 Conclusions
We have developed a reproducible method that yields cationic CNs that
successfully loaded HTN3. The HTN3-loaded CNs were able to selectively swell under
acidic pH conditions, releasing the loaded HTN3. The amount of HTN3 released was
proportional to the acidity of the environment. The observed pH-responsive release is
important because the oral cavity acidifies every time after dietary carbohydrate intake.
The released protein may promote oral homeostasis to prevent dental caries. Protection of
loaded HTN3 against enzymatic degradation was evaluated under the presence of 10-fold
diluted human saliva. The delivery system provided a two-fold increase in survival time
compared against free HTN3. The prolonged survival time allows the formulation to be
administered less frequently, and releases protein to offer protection every time after sugar
consumption that happens numerous times a day. Preliminary results have suggested the
blank and HTN3-loaded CNs have the potential to reduce biofilm growth, supported by
lowered biofilm mass and reduced bacterial cell viability. The most intriguing finding is
the blank CNs performed on par with the gold standard fluoride. Results from the biofilm
experiment suggested blank CNs alone are sufficient in reducing biofilm growth. One
possible application would be to incorporate blank CNs formulation directly into a mouth
wash as a preventative measure to address dental caries. Some advantages of using blank
CNs alone are the simplified preparation protocol, and reduced cost without HTN3.
There are some limitations to this study. Firstly, the HTN3-loaded CNs were
visualized by TEM. However, the 2D-visualization could not explicitly illustrate if HTN3
was loaded inside of the CNs or outside across the surface of CNs. Secondly, the whole
saliva was diluted by 10-fold to better capture the degradation kinetics of HTN3, since the
degradation would have happened too rapidly at the original concentration, making it a
challenge to study. However, this does not simulate the real proteolytic environment.
Lastly, the quantity of CNs absorbed onto the HA discs was not quantified due to
limitations in methodology.
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3.2 Future Work
Future studies can take on two directions. First the possibility of integrating blank
CNs into dental hygiene products to prevent dental caries could be further explored. The
toxicity profile of the blank CNs needs to be evaluated. Coverage of CNs on tooth surface
also needs to be determined.
The second focus would be to continue investigating HTN3-loaded CNs. Saliva
collected from caries-active patients will be used to characterize the extent of release from
CNs and the kinetics of protein release. Modifications to the preparation of CNs will be
attempted to enhance the protection offered against enzymatic degradation. Biofilm
experiments will include a larger sample size to compensate for the high sample variability.
Treatment time will also be optimized, as only a 2-hour treatment time was evaluated so
far. 2 hours is the time required for pellicle formation, but it may not be the optimized time
for the attachment of CNs onto the discs. The amount of protein loaded was based on the
IC50 obtained from the killing assay. More HTN3 can be loaded, and/or lower chitosan
concentration should be studied to better distinguish between unloaded and HTN3-loaded
CN treatment groups. Another potential treatment group worth investigating would be a
combination treatment of HTN3 loaded CNs and fluoride. The newly proposed treatment
group is inspired by previous studies in the chemotherapy field that have achieved
synergistic effects through combination treatments (Ren et al. 2009; Cai et al. 2015;
Mukherjee et al. 2017). A synergistic effect occurs when two or more therapeutic agents
combine to create an effect that is greater than the sum of their individual effects. Lastly,
the delivery system could also be applied to load other functional salivary proteins, such
as HTN1 and HTN5. Other functional salivary proteins could also be loaded through
modified loading protocol. A variety of proteins could be loaded to formulate a
multifunctional delivery system.
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